secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K/A
Filed at:   2026-08-11T00:16:16+00:00
Accession:  0001493152-26-036936
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals schedules Aug 13 release of Q1 FY2027 results, Aug 14 call
--------------------------------------------------------------------------------

- Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
- Conference call Friday, August 14, 2026 at 11:30 AM EDT; dial-in 1-800-346-7359 (US), 1-973-528-0008 (intl), conference number 98840.
- 8-K/A amends prior notice, correcting event dates from November to August 2026.
- Stockholder questions accepted via dianne@elitepharma.com; general Qs by Aug 12, financial Qs by Aug 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226036936/0001493152-26-036936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226036936/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer